- The Impact of LRRK2 G2019S on Parkinson’s Disease: Clinical Phenotype and Treatment in Tunisian Patients
-
Barreh GA, Sghaier I, Abida Y, Gharbi A, Nasri A, Mrabet S, Souissi A, Djebara MB, Trabelsi S, Kacem I, Gargouri-Berrechid A, Gouider R
- KMID: 2558074
- J Mov Disord.
- 2024 Jul;17(3):294-303.
- doi: 10.14802/jmd.23276
Objective LRRK2-G2019S is the most frequent mutation in North African Parkinson’s disease (PD) patients. Data on its impact on disease progression and treatment response remain elusive. Therefore, we investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect
-
Nasri A, Sghaier I, Neji A, Gharbi A, Abida Y, Mrabet S, Gargouri A, Djebara MB, Kacem I, Gouider R
- KMID: 2554690
- J Mov Disord.
- 2024 Apr;17(2):158-170.
- doi: 10.14802/jmd.23178
Objective Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder encompassing several phenotypes with various motor and cognitive deficits. We aimed to study motor and cognitive characteristics across PSP phenotypes... -
- CITED
-
- Close
- SHARE
-
- Close
